Article Text

PDF
In utero drugs of abuse exposure testing for newborn twins
  1. Ping Wang,
  2. Claudia P Molina,
  3. Joyce E Maldonado,
  4. David W Bernard
  1. Department of Pathology, The Methodist Hospital System, Houston, Texas, USA
  1. Correspondence to Ping Wang, The Methodist Hospital, 6565 Fannin St. MS 205, Houston, TX 77030, USA; pwang{at}tmhs.org

Abstract

This report describes testing of a case of in utero drugs of abuse exposure in which discordant results were seen between urine and meconium, and between twin meconium samples. The discordance between urine and meconium could be explained by the differences in detection window, threshold concentration and screening technology, and the discordance between dizygotic twin meconium samples could be explained by the differences in drug diffusion and placental and fetal biotransformation of drugs. The meconium sample of one twin screened negative for benzodiazepines was reported positive in the confirmation assay with higher sensitivity and a lower cut-off concentration. Negative screening results of drugs of abuse should be interpreted with caution, taking into account matrix type, reactivity of drugs in the assay and cut-off concentration. If screening results are inconsistent with each other or with the clinical scenario, confirmation testing using more sensitive and specific methods with lower cut-offs is warranted.

  • In utero
  • drugs of abuse
  • twin
  • urine
  • meconium
  • drug abuse
  • toxicology

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Not received, as the patient has been lost to follow-up.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.